1J uniper E F.Health2related quality of life in rhinitis.In:Naclerio R M,Durham S R,Mygind N.Rhinitis2mecha2nism and management[M].New York:Marcel Dekker Inc,1999:135-146.
4Bennett ML, Fountain JM, McCarty MA, et al. Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma. Am J Contact Dermat, 2001,12: 193-196.
5Cunha AP, Mota AV, Barros MA, et al. Corticosteroid contact allergy from a nasal spray in a child. Contact Dermatitis, 2003,48: 277.
6Iglesias-Cadarso A, Diaz C, Laguna JJ, et al. Allergic contact dermatomucositis to budesonide. J Allergy Clin Immunol, 1994,94(3 Pt 1): 559-560.
7Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med, 1997,337: 8-14.
8Drake AJ, Howells RJ, Shield JP, et al. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ, 2002,324: 1081-1082.
9Wilson AM, Sims EJ, McFarlane LC, et al. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis. J Allergy Clin Immunol, 1998,102(4 Pt 1): 598-604.
10Bachert C, Lukat KF, Lange B. Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity in healthy volunteers. Clin Exp Allergy, 2004, 34: 85-90.
